
Glycfit Triog 1mg/500mg/15mg Tablet
Marketer
Plethico Pharmaceuticals Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glycfit Triog 1mg/500mg/15mg Tablet
Trioglyn 1mg/500mg/15mg tablets combine medications to effectively manage blood glucose. This regimen, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin utilization, consequently reducing blood sugar. Dosage and duration for Trioglyn 1mg/500mg/15mg tablets should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case, omit the missed dose and resume the usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic drugs, alcohol, or skipped meals increases hypoglycemia risk. Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions must be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals should also seek medical counsel. Kidney function tests will be assessed prior to treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Uses of Glycfit Triog 1mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glycfit Triog 1mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glycfit Triog 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.
Common Side effects of Glycfit Triog 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glycfit Triog 1mg/500mg/15mg Tablet:
Consume Glycfit Triog 1mg/500mg/15mg tablets precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glycfit Triog 1mg/500mg/15mg Tablet works:
Glycfit Triog 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glycfit Triog 1mg/500mg/15mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Glycfit Triog 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glycfit Triog 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glycfit Triog 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glycfit Triog 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glycfit Triog 1mg/500mg/15mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glycfit Triog 1mg/500mg/15mg Tablet :
Should you forget a Glycfit Triog 1mg/500mg/15mg Tablet dose, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glycfit Triog 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
